BRPI0411830A - método de proteção de compostos bio-ativos e composições contendo os mesmos - Google Patents

método de proteção de compostos bio-ativos e composições contendo os mesmos

Info

Publication number
BRPI0411830A
BRPI0411830A BRPI0411830-8A BRPI0411830A BRPI0411830A BR PI0411830 A BRPI0411830 A BR PI0411830A BR PI0411830 A BRPI0411830 A BR PI0411830A BR PI0411830 A BRPI0411830 A BR PI0411830A
Authority
BR
Brazil
Prior art keywords
protection
compositions containing
bioactive compounds
mammalian
bioactive
Prior art date
Application number
BRPI0411830-8A
Other languages
English (en)
Inventor
Amir Barzilay
Hagit Koren Licthig
Original Assignee
Nutrinia Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nutrinia Ltd filed Critical Nutrinia Ltd
Publication of BRPI0411830A publication Critical patent/BRPI0411830A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/142—Amino acids; Derivatives thereof
    • A23K20/147—Polymeric derivatives, e.g. peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/168—Steroids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/184—Hormones
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/20—Inorganic substances, e.g. oligoelements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K40/00—Shaping or working-up of animal feeding-stuffs
    • A23K40/25—Shaping or working-up of animal feeding-stuffs by extrusion
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K40/00—Shaping or working-up of animal feeding-stuffs
    • A23K40/30—Shaping or working-up of animal feeding-stuffs by encapsulating; by coating
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/60—Feeding-stuffs specially adapted for particular animals for weanlings
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Abstract

"MéTODO DE PROTEçãO DE COMPOSTOS BIO-ATIVOS E COMPOSIçõES CONTENDO OS MESMOS". A presente invenção se refere a meios para proteger materiais bio-ativos em comida para mamíferos ou formulações de alimento usadas para melhorar o estado de saúde de mamíferos.
BRPI0411830-8A 2003-06-20 2004-06-17 método de proteção de compostos bio-ativos e composições contendo os mesmos BRPI0411830A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US47986003P 2003-06-20 2003-06-20
US54816404P 2004-03-01 2004-03-01
PCT/IL2004/000532 WO2004112494A2 (en) 2003-06-20 2004-06-17 Bioactive compounds protection method and compositions containing the same

Publications (1)

Publication Number Publication Date
BRPI0411830A true BRPI0411830A (pt) 2006-08-08

Family

ID=33544417

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0411830-8A BRPI0411830A (pt) 2003-06-20 2004-06-17 método de proteção de compostos bio-ativos e composições contendo os mesmos

Country Status (8)

Country Link
US (6) US8877232B2 (pt)
EP (1) EP1659873A4 (pt)
JP (1) JP2007520202A (pt)
KR (2) KR101183565B1 (pt)
CN (1) CN103583696A (pt)
BR (1) BRPI0411830A (pt)
RU (1) RU2006101616A (pt)
WO (1) WO2004112494A2 (pt)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2006101616A (ru) 2003-06-20 2006-07-27 Ньютриниа Лтд. (Il) Способ защиты биоактивных соединений и композиции, содержащие указанные соединения
EP1758464A4 (en) * 2004-05-24 2012-10-24 Nutrinia Ltd NUTRITIONAL FOOD AND SUPPLEMENT, ITS COMPOSITION, PROCESSING AND METHOD FOR ITS USE
ES2435538T3 (es) * 2007-06-07 2013-12-20 Nutrinia Ltd. Medios y métodos para potenciar la ganancia de peso en aves de corral
FI120642B (fi) * 2007-10-19 2010-01-15 Biomed Oy Mikrokapseloidut liposomikoostumukset
US20090202613A1 (en) * 2008-02-11 2009-08-13 Tabatchnick Fine Foods, Inc. Nutritionally Enhanced Therapeutic Preventative Food Supplement and Method of Making Same
AU2009285725A1 (en) * 2008-08-29 2010-03-04 The General Hospital Corporation Methods of modulating gastrointestinal tract flora levels with alkaline phosphatase
US9504274B2 (en) * 2009-01-27 2016-11-29 Frito-Lay North America, Inc. Methods of flavor encapsulation and matrix-assisted concentration of aqueous foods and products produced therefrom
US7953829B2 (en) * 2009-02-05 2011-05-31 At&T Mobility Ii Llc System and method for quality of service (QoS) parameter change
EP2533802B1 (en) 2010-02-12 2015-08-19 The General Hospital Corporation Methods of reducing or inhibiting toxic effects associated with a bacterial infection using alkaline phosphatase
JP2012152138A (ja) * 2011-01-26 2012-08-16 Biolink Hanbai Co Ltd 食品組成物
CN104114036B (zh) * 2012-02-16 2016-05-18 伊莱利利公司 用于减少动物废物的环境影响的方法和组合物
EP2838553A4 (en) * 2012-04-18 2015-09-23 Nutrinia Ltd STRENGTHENING THE GROWTH OF INFANTS
WO2013179290A1 (en) 2012-05-31 2013-12-05 Nutrinia Ltd. Insulin-containing infant formula
FR2998450A1 (fr) * 2012-11-26 2014-05-30 Dominique Hooreman Utilisation d'un complexe enzymatique dans l'alimentation des animaux d'elevage
EP2968579B1 (en) * 2013-03-13 2020-04-15 Intervet International B.V. Stable bioactive substances and methods of making
JP5926409B2 (ja) 2013-08-21 2016-05-25 株式会社Ｎｒｌファーマ マイクロ微粒子の製造方法
AU2017237164A1 (en) * 2016-03-24 2018-10-11 Nutrinia Ltd. Use of insulin for promoting gastric emptying
CA3057089A1 (en) 2017-03-21 2018-09-27 Synthetic Biologics, Inc. Alkaline phosphatase formulations
EP3427725A1 (en) * 2017-07-12 2019-01-16 Roquette Freres Cross-linked maltodextrins for the oral delivery of biological actives
US11338020B2 (en) 2018-01-09 2022-05-24 Synthetic Biologics, Inc. Alkaline phosphatase agents for treatment of neurodevelopmental disorders
EP3773686B1 (en) 2018-03-20 2023-06-07 Theriva Biologics, Inc. Alkaline phosphatase agents for treatment of radiation disorders
EP3768302A4 (en) 2018-03-20 2021-12-15 Synthetic Biologics, Inc. INTESTINAL ALKALINE PHOSPHATASE FORMULATIONS

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0321481B1 (en) 1986-08-28 1994-06-01 Enzacor Properties Limited Microgranular preparation useful in the delivery of biologically active materials to the intestinal regions of animals
US5356625A (en) 1986-08-28 1994-10-18 Enzacor Properties Limited Microgranular preparation useful in the delivery of biologically active materials to the intestinal regions of animals
FR2606597B1 (fr) * 1986-11-17 1989-01-27 Rhone Poulenc Sante Nouvelle composition pour l'alimentation des ruminants contenant une substance biologiquement active et sa preparation
US5013569A (en) * 1990-05-21 1991-05-07 Century Laboratories, Inc. Infant formula
US5418010A (en) * 1990-10-05 1995-05-23 Griffith Laboratories Worldwide, Inc. Microencapsulation process
DE4100920A1 (de) * 1991-01-15 1992-07-16 Degussa Wirkstoffzubereitung zur oralen verabreichung an wiederkaeuer
US5160742A (en) 1991-12-31 1992-11-03 Abbott Laboratories System for delivering an active substance for sustained release
US5360614A (en) * 1993-04-26 1994-11-01 The Estee Corporation Method of controlling the release of carbohydrates by encapsulation and composition therefor
US5405637A (en) 1993-06-30 1995-04-11 Bristol-Myers Squibb Company Milk protein partial hydrolysate and infant formula containing same
US5531989A (en) * 1994-10-28 1996-07-02 Metagenics, Inc. Immunoglobulin and fiber-containing composition for human gastrointestinal health
ATE207312T1 (de) * 1995-06-29 2001-11-15 Nestle Sa Verfahren zur verkapselung eines kernmaterials mit einem polymer durch hochdruckbehandlung
JPH10155428A (ja) 1996-12-04 1998-06-16 Shida Kanzume Kk 毛づや改善剤及び毛づやの改善方法、並びに健康食品
JPH119196A (ja) 1997-06-24 1999-01-19 Meiji Seika Kaisha Ltd キトサンによる家畜の損耗防止の方法
US6638621B2 (en) * 2000-08-16 2003-10-28 Lyotropic Therapeutics, Inc. Coated particles, methods of making and using
KR100551221B1 (ko) * 1997-09-09 2006-02-10 리오트로픽테라피우틱스 인코퍼레이션 코팅된 입자, 그 제조방법 및 그 사용방법
ATE413889T1 (de) 1998-06-05 2008-11-15 Nutrinia Ltd Insulin angereichertes säuglingsnährpräparat
US6399090B1 (en) * 1998-06-05 2002-06-04 Insotech Ltd. Insulin supplemented infant formula
JP2000050793A (ja) 1998-08-07 2000-02-22 Meiji Milk Prod Co Ltd 人工乳組成物
JP2000116320A (ja) 1998-10-13 2000-04-25 Bingu Gure:Kk 乳酸菌カプセル入りヨーグルト及びその製造方法
GB2345836A (en) * 1999-01-25 2000-07-26 Charleville Res Animal milk replacer
US7374779B2 (en) * 1999-02-26 2008-05-20 Lipocine, Inc. Pharmaceutical formulations and systems for improved absorption and multistage release of active agents
PL207930B1 (pl) * 2000-05-25 2011-02-28 Nestle Sa Zastosowanie wyizolowanego probiotycznego szczepu bakterii kwasu mlekowego o aktywności probiotycznej, kompozycja pokarmowa i izolowany szczep bakterii kwasu mlekowego
JP2002209513A (ja) * 2000-12-15 2002-07-30 Bingu-Gure:Kk 栄養成分を含有する多数のカプセル入り強化牛乳
EP1214892B1 (en) 2000-12-15 2005-03-09 Quest International B.V. A moisture and oxygen stable composition and a process for obtaining said composition
AUPR272901A0 (en) 2001-01-25 2001-02-22 Gainful Plan Limited Method of preparing biological materials and preparations produced using same
EA007301B1 (ru) 2001-05-14 2006-08-25 Василий Петрович Андрейчук Биологически активная добавка к пище и биологически активная кормовая добавка для профилактики йодной недостаточности и оптимизации йодного обмена, пищевой и кормовой продукты, содержащие указанные добавки
WO2002094224A1 (en) 2001-05-23 2002-11-28 Institut National De La Recherche Scientifique Biocompatible compositions as carriers or excipients for pharmaceutical and nutraceutical formulations and for good protection
US20030044458A1 (en) 2001-08-06 2003-03-06 Curtis Wright Oral dosage form comprising a therapeutic agent and an adverse-effect agent
US6951655B2 (en) * 2001-10-11 2005-10-04 Imi Biomed, Inc. Pro-micelle pharmaceutical compositions
US20030175382A1 (en) 2002-03-14 2003-09-18 Dally Vernetta L. Heat released encapsulated yeast
US20030175403A1 (en) * 2002-03-14 2003-09-18 Gurin Michael H. Potentiated bioactive additives and method of use
AU2003243926A1 (en) 2002-07-01 2004-01-19 Novozymes A/S Stabilization of granules
US6835397B2 (en) * 2002-12-23 2004-12-28 Balchem Corporation Controlled release encapsulated bioactive substances
RU2006101616A (ru) 2003-06-20 2006-07-27 Ньютриниа Лтд. (Il) Способ защиты биоактивных соединений и композиции, содержащие указанные соединения
EP1758464A4 (en) 2004-05-24 2012-10-24 Nutrinia Ltd NUTRITIONAL FOOD AND SUPPLEMENT, ITS COMPOSITION, PROCESSING AND METHOD FOR ITS USE
US7943733B2 (en) 2007-12-20 2011-05-17 University Of Southern California Spacers to increase the expression of recombinant fusion proteins

Also Published As

Publication number Publication date
US20060147494A1 (en) 2006-07-06
US20150118280A1 (en) 2015-04-30
US20190167594A1 (en) 2019-06-06
US20200016083A1 (en) 2020-01-16
US20190038560A1 (en) 2019-02-07
WO2004112494A2 (en) 2004-12-29
CN103583696A (zh) 2014-02-19
EP1659873A2 (en) 2006-05-31
KR20120080241A (ko) 2012-07-16
EP1659873A4 (en) 2011-06-08
KR20060069357A (ko) 2006-06-21
US9943485B2 (en) 2018-04-17
KR101183565B1 (ko) 2012-09-17
US9750699B2 (en) 2017-09-05
WO2004112494A3 (en) 2005-11-10
US8877232B2 (en) 2014-11-04
US20170340567A1 (en) 2017-11-30
JP2007520202A (ja) 2007-07-26
RU2006101616A (ru) 2006-07-27

Similar Documents

Publication Publication Date Title
BRPI0411830A (pt) método de proteção de compostos bio-ativos e composições contendo os mesmos
BR0307833A (pt) Sìntese controlada de ziprasidona e suas composições
BR9911488A (pt) Composto, uso do mesmo, composição farmacêutica, e, processos para tratamento ou de profilaxia de doenças inflamatórias, e para a preparação de um composto
DE69410092T2 (de) Phenyl heterocyclen als cyclooxygenase-2 inhibitoren
CY1105349T1 (el) Θειαζολυλ-αναστολεις τυροκινασεων της οικογενειας tec
BR9911482A (pt) Composto, composição farmacêutica, uso do composto, e, processos para o tratamento ou profilaxia de doenças inflamatórias, e para a preparação de um composto
AR020345A1 (es) Pirazol-carboxanilidas, procedimiento para su obtencion, composiciones, empleo de dichos compuestos y procedimiento para la lucha contra microorganismos indeseables, y procedimiento para la obtencion de dichas composiciones.
BR9908004A (pt) Composto, composição e método para prevençãoou supressão de uma infecção viral
BR0313041A (pt) Compostos; composições farmacêuticas; método para o tratamento e/ou profilaxia de doenças que estão associadas à modulação dos receptores de cb1; e uso de compostos
HUP0003297A2 (hu) Szinergetikus hatású biocidkészítmény
PL378107A1 (pl) 1,2,4-triazyny hamujące HIV
BR0309342A (pt) Composto, composição farmacêutica, uso de um composto, e, método de tratamento ou profilaxia de doenças ou condições humanas
HK1113790A1 (en) Selurampanel
CR7956A (es) Oxazolidinonas de indolona antibacterial intermedios para su preparacion y composiciones farmaceuticas que contienen los mismos
DE60332101D1 (de) Antimikrobielle zusammensetzung
BRPI0506718A (pt) compostos, processo de preparação dos mesmos, e, composição farmacêutica ou cosmética
BR0213066A (pt) Compostos de cianoacetila
WO2003050067A3 (fr) Analogues de la vitamine d
DE59909607D1 (de) Tan-1057 derivate
ATE430472T1 (de) N-phenyl-(4-pyridyl)azinylaminderivate als pflanzenschutzmittel
BR0315106A (pt) Derivados antimicrobianos de [3.1.0]oxazolidinona bicìclica
FR2876875B1 (fr) Protection d'ingredients alimentaires bioactifs par encapsulation
BR8402938A (pt) Compostos,processo para sua preparacao,composicoes microbicidas,e processos para combate ou impedimento de uma infestacao de plantas de cultura por microorganismos e para conservacao ou para protecao de material de armazenagem
ATE311845T1 (de) Pharmazeutische und kosmetische zubereitungen enthaltend urocaninsäurederivate als antioxidationsmittel oder radikalenabfangermittel
ES2164454T3 (es) Nuevos compuestos derivados de acido alquilendiamina di o tri-acetico, su procedimiento de preparacion, su utilizacion en composiciones cosmeticas y farmaceuticas y composiciones que los contienen.

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal acc. article 33 of ipl - extension of time limit for request of examination expired